[ORGANIZATION]
Just – Evotec Biologics
Featured in 2 tracked stories · first seen
Situations
Evotec clinical trial for orthopoxvirus antibodies
2 clusters · 4 sources · last updated
Latest: Biotechnology firms advance clinical trials for viral and transplant therapies
Evotec, through its subsidiary Just – Evotec Biologics, has initiated a Phase 1 clinical trial for JST-018. This investigational cocktail of monoclonal antibodies is designed to target orthopoxviruses, which include the